Nasal microbiota transplantation: a gateway to novel treatments.

IF 14 1区生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

Trends in Microbiology Pub Date : 2025-03-01 Epub Date: 2025-01-14 DOI:10.1016/j.tim.2024.12.010

Sudhanshu Shekhar, Martin Schwarzer, Achal Dhariwal, Fernanda Cristina Petersen

引用次数: 0

Abstract

Two recent studies have highlighted the potential of nasal microbiota transplantation (NMT) to treat chronic rhinosinusitis (CRS). Here we evaluate these findings and propose that lessons from fecal microbiota transplantation (FMT) could guide NMT development, with possible implications for combating antimicrobial resistance in respiratory infections.

查看原文本刊更多论文

鼻微生物群移植：通向新疗法的大门。

最近的两项研究强调了鼻微生物群移植（NMT）治疗慢性鼻窦炎（CRS）的潜力。在这里，我们评估了这些发现，并提出粪便微生物群移植（FMT）的经验教训可以指导NMT的发展，可能对对抗呼吸道感染的抗菌素耐药性具有指导意义。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Trends in Microbiology 生物-生化与分子生物学

CiteScore

25.30

自引率

0.60%

发文量

193

审稿时长

6-12 weeks

期刊介绍： Trends in Microbiology serves as a comprehensive, multidisciplinary forum for discussing various aspects of microbiology, spanning cell biology, immunology, genetics, evolution, virology, bacteriology, protozoology, and mycology. In the rapidly evolving field of microbiology, technological advancements, especially in genome sequencing, impact prokaryote biology from pathogens to extremophiles, influencing developments in drugs, vaccines, and industrial enzyme research.